Health tech deals

  • Pristyn Care raises $53m funding

    Surgical health tech start-up Pristyn Care said it has raised $53m in a Series-D round of funding led by US investment fund Tiger Global Management. Pristyn Care’s valuation has since risen to $550m, more than doubling from the $250 million it had been valued at 6 months ago. The latest round of funding is led [...]

  • WellTech scaleup Frog Systems raises £846K in new funding round

    Mental health and wellbeing technology company Frog Systems has participated in a new funding round that has raised more than three-quarters of a million pounds. The latest capital raise was opened up to members of staff as well as existing shareholders and totalled £846,000, with shares being priced at a 10 per cent premium over [...]

  • A record year for digital health investment

    Figures from Rockhealth show that digital health investment grew by almost 50 per cent in the first three quarters of 2021 compared to the previous year. Here we report on some of the biggest deals of the year so far.   It has been a record-breaking year for digital health investment. According to Rockhealth, 2021 has [...]

  • Charco Neurotech secures $10m investment

    Medtech business Charco Neurotech, which develops solutions for people living with Parkinson’s, has announced a $10million seed investment round to support its continued development.  The financing is the largest European seed round in 2021 and the sixth largest globally for healthtech devices, according to Pitchbook. Charco, an Imperial College spinout, has developed the therapeutic device [...]

  • Readying for sale in the MedTech sector

    Mark Herbert, managing director at corporate finance firm Shawpoint and Michael Squirrell, corporate partner at law firm Shakespeare Martineau, explore the steps MedTech companies can take in advance of a sale or investment. An ageing population and increasing public health expenditure makes the NHS an appealing market to overseas healthcare investors, with UK MedTech businesses [...]

  • Medical AI company Thirona backed by HERAN Partners and Borski Fund

    AI-powered medical image analysis specialist Thirona has received funding from Belgian investment fund HERAN Partners and the Netherlands-based Borski Fund. Thirona develops artificial intelligence solutions for lung and retinal image analysis. It focuses on common diseases such as Asthma, COPD, Age-related Macular Degeneration and Diabetic Retinopathy, as well as rare and complex conditions, including Cystic Fibrosis and Idiopathic [...]

  • Sunak confirms £2.1bn to improve NHS digital technology

    UK chancellor Rishi Sunak has pledged £2.1bn to improve NHS digital technology in today's budget. Sunak said the funding will support the “innovative use of digital technology so hospitals and other care organisations are as connected and efficient as possible". He said this will free up valuable NHS staff time, allowing them to spend more [...]

  • DayOne Accelerator wants to improve lives for patients

    Deborah Johnson reports on the DayOne Accelerator, Switzerland’s engine room of health innovation and enterprise As a globally-recognised centre of health tech innovation, the Basel Area is a key location for driving the sector forward, with its influence felt across Europe and, increasingly, the wider world. While digital-driven solutions are playing an ever-more central role [...]

  • Giving health innovations wings

    Health Tech World goes inside the mind of a health tech investor in an interview with Pierre Socha of Amadeus Capital Partners.   Amadeus Capital Partners is a global ‘deep-tech’ investing firm based in Cambridge. Founded in 1997, the firm has since backed more than 180 companies and raised over US$1bn. It focuses on several industries, [...]

  • 100 projects backed by £113m innovation fund

    Health tech innovators are among those being backed by a new £113m UK government funding scheme aimed at finding the next generation of science leaders. The funding is part of the government’s aim of increasing public R&D spending by £22bn by 2024/25. Anti-epilepsy tech and new types of therapy to treat chronic conditions such as [...]